People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Monitored Therapeutics, Inc. | — | Pharma | Series A | $8.5M | $82.4M | 2020 |
Barry Sugarman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Barry Sugarman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Shary | 1 | 11 |
| Michael Taylor | 1 | 7 |
| James Kamnikar | 1 | 2 |
| Steve Han | 1 | 1 |
| Alex Stenzler | 1 | 1 |
| Alex Charles Stenzler | 1 | 1 |
| Michael Stock Taylor | 1 | 1 |
| William Stock Ross | 1 | 1 |
| William Charles Zimlich | 1 | 1 |
| William Ross | 1 | 1 |
| Kamnikar Jim | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.